Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gait as Predictor of Cognitive Decline, Dementia, and Risk of Falls in MCI. A Cohort Study

NCT03020381 is registered in ClinicalTrials.gov with Manuel Montero Odasso as lead sponsor.

NCT NCT03020381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03020381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gait as Predictor of Cognitive Decline, Dementia, and Risk of Falls in MCI. A Cohort Study
Lead sponsor
Manuel Montero Odasso
Phase
Observational
Overall status
Recruiting
Start date
December 31, 2007
Completion date
January 31, 2033
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cerebral atrophy, dementia, gait apraxia, mild cognitive impairment, subjective cognitive impairment